MLANA anticorps (AA 1-37) (FITC)
Aperçu rapide pour MLANA anticorps (AA 1-37) (FITC) (ABIN8008808)
Antigène
Voir toutes MLANA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-37
-
Fonction
- Anti-Melan-A/MLANA Antibody FITC Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- E.coli-derived human Melan-A/MLANA recombinant protein (Position: M1-L37).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, Optimal dilutions should be determined by end users.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- MLANA (Melan A (MLANA))
-
Autre désignation
- MLANA
-
Sujet
-
Background: MLANA (Melan-A, also known as MART1, MART-1), located on 9p24.1, is a Protein Coding gene. The gene produces a 13157 Da protein composed of 118 amino acids. MLANA is a hydrophobic transmembrane protein without glycosylation sites highly enriched in early melanosomes. MLANA is expressed in skin and retinae melanocytes and the majority of melanoma tumors, but it is absent from other tissues and tumors. Diseases such as Melanoma In Congenital Melanocytic Nevus and Angiomyolipoma are associated with MLANA. The related pathways of MLANA include NF-kappaB Signaling.
Gene Full Name: melan-A
-
ID gène
- 2315
-
UniProt
- Q16655
Antigène
-